Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (84)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Eisensehr, I.
Right arrow Articles by Tatsch, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eisensehr, I.
Right arrow Articles by Tatsch, K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 123, No. 6, 1155-1160, June 2000
© 2000 Oxford University Press

Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder

Comparison with Parkinson's disease and controls

I. Eisensehr1, R. Linke2, S. Noachtar1, J. Schwarz1, F. J. Gildehaus2 and K. Tatsch2

1 Departments of Neurology and 2 Nuclear Medicine, University of Munich, Germany

Correspondence to: Dr Ilonka Eisensehr, Department of Neurology, University of Munich, Klinikum Grosshadern, Marchioninistrasse 15, 81377 Munich, Germany E-mail: eisen{at}nefo.med.uni-muenchen.de

Rapid eye movement (REM) sleep behaviour disorder (RBD) is characterized by complex behaviour during REM sleep. The aetiology of this disorder is still unknown, but a recent study showed an association between RBD and Parkinson's disease. We therefore studied striatal postsynaptic dopamine D2 receptor density with [123I](S)-2-hydroxy-3-iodo-6-methoxy-(1-ethyl-2-pyrrolidinylmethyl) benzamide ([123I]IBZM) and the striatal presynaptic dopamine transporter with (N)-(3-iodopropene-2-yl)-2ß-carbomethoxy-3ß-(4-chlorophenyl) tropane ([123I]IPT) using single-photon emission computed tomography (SPECT) in patients with idiopathic RBD. We compared the [123I]IPT-SPECT results of five patients with polysomnographically confirmed idiopathic RBD with the [123I]IPT-SPECTs of seven age- and sex-matched controls without a history of sleep disorders, and of 14 patients with Parkinson's disease (Hoehn and Yahr stage I). All RBD patients had significantly reduced striatal [123I]IPT binding compared with the controls (RBD: right, 2.94 ± 0.32, left, 3.03 ± 0.41; controls: right, 4.41 ± 0.17, left, 4.34 ± 0.21; P = 0.003), but significantly higher striatal [123I]IPT binding compared with the striatum contralateral to the symptomatic body side of the Parkinson's disease patients (Parkinson's disease: ipsilateral, 3.17 ± 0.36, P = 0.298; contralateral, 2.51 ± 0.31, P = 0.019). Uptake of [123I]IBZM was not significantly different in the RBD group compared with the controls. This study demonstrates that [123I]IPT-SPECT is a useful diagnostic tool in RBD and that reduced striatal dopamine transporters may be a pathophysiological mechanism of idiopathic RBD. (Results are given as mean ± standard deviation.)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Neurol. Neurosurg. PsychiatryHome page
M D Gjerstad, B Boeve, T Wentzel-Larsen, D Aarsland, and J P Larsen
Occurrence and clinical correlates of REM sleep behaviour disorder in patients with Parkinson's disease over time
J. Neurol. Neurosurg. Psychiatry, April 1, 2008; 79(4): 387 - 391.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
B. F. Boeve, M. H. Silber, C. B. Saper, T. J. Ferman, D. W. Dickson, J. E. Parisi, E. E. Benarroch, J. E. Ahlskog, G. E. Smith, R. C. Caselli, et al.
Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease
Brain, November 1, 2007; 130(11): 2770 - 2788.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
J. J Gugger and M. L Wagner
Rapid Eye Movement Sleep Behavior Disorder
Ann. Pharmacother., November 1, 2007; 41(11): 1833 - 1841.
[Abstract] [Full Text] [PDF]

Home page
 PNHome page
P. Reading
Parasomnias: the spectrum of things that go bump in the night
Practical Neurology, February 1, 2007; 7(1): 6 - 15.
[Full Text] [PDF]

Home page
 NeurologyHome page
S. Mazza, J. P. Soucy, P. Gravel, M. Michaud, R. Postuma, J. Massicotte-Marquez, A. Decary, and J. Montplaisir
Assessing whole brain perfusion changes in patients with REM sleep behavior disorder.
Neurology, November 14, 2006; 67(9): 1618 - 1622.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
J.-F. Gagnon, R. B. Postuma, and J. Montplaisir
Update on the pharmacology of REM sleep behavior disorder.
Neurology, September 12, 2006; 67(5): 742 - 747.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
B. F. Boeve, S.-C. Lin, A. Strongosky, D. W. Dickson, and Z. K. Wszolek
Absence of Rapid Eye Movement Sleep Behavior Disorder in 11 Members of the Pallidopontonigral Degeneration Kindred
Arch Neurol, February 1, 2006; 63(2): 268 - 272.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
R. D. Abbott, G. W. Ross, L. R. White, C. M. Tanner, K. H. Masaki, J. S. Nelson, J. D. Curb, and H. Petrovitch
Excessive daytime sleepiness and subsequent development of Parkinson disease
Neurology, November 8, 2005; 65(9): 1442 - 1446.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
A. Iranzo, J. Santamaria, D. B. Rye, F. Valldeoriola, M. J. Marti, E. Munoz, I. Vilaseca, and E. Tolosa
Characteristics of idiopathic REM sleep behavior disorder and that associated with MSA and PD
Neurology, July 26, 2005; 65(2): 247 - 252.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
M. L. Fantini, L. Ferini-Strambi, and J. Montplaisir
Idiopathic REM sleep behavior disorder: Toward a better nosologic definition
Neurology, March 8, 2005; 64(5): 780 - 786.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
K. Stiasny-Kolster, Y. Doerr, J. C. Moller, H. Hoffken, T. M. Behr, W. H. Oertel, and G. Mayer
Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for {alpha}-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT
Brain, January 1, 2005; 128(1): 126 - 137.
[Abstract] [Full Text] [PDF]

Home page
 J Geriatr Psychiatry NeurolHome page
B. F. Boeve, M. H. Silber, and T. J. Ferman
REM Sleep Behavior Disorder in Parkinson's Disease and Dementia with Lewy Bodies
J Geriatr Psychiatry Neurol, September 1, 2004; 17(3): 146 - 157.
[Abstract] [PDF]

Home page
 NeurologyHome page
B. Phillips
Movement disorders: A sleep specialist's perspective
Neurology, March 9, 2004; 62(90052): S9 - 16.
[Abstract] [Full Text]

Home page
 NeurologyHome page
J.-F. Gagnon, M. L. Fantini, M.-A. Bedard, D. Petit, J. Carrier, S. Rompre, A. Decary, M. Panisset, and J. Montplaisir
Association between waking EEG slowing and REM sleep behavior disorder in PD without dementia
Neurology, February 10, 2004; 62(3): 401 - 406.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
J. K. Matheson and C. B. Saper
REM sleep behavior disorder: A dopaminergic deficiency disorder?
Neurology, November 25, 2003; 61(10): 1328 - 1329.
[Full Text] [PDF]

Home page
 NeurologyHome page
M.L. Fantini, J.-F. Gagnon, D. Filipini, and J. Montplaisir
The effects of pramipexole in REM sleep behavior disorder
Neurology, November 25, 2003; 61(10): 1418 - 1420.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
S. Gilman, R. A. Koeppe, R. D. Chervin, F. B. Consens, R. Little, H. An, L. Junck, and M. Heumann
REM sleep behavior disorder is related to striatal monoaminergic deficit in MSA
Neurology, July 8, 2003; 61(1): 29 - 34.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
B. F. Boeve, M. H. Silber, J. E. Parisi, D. W. Dickson, T. J. Ferman, E. E. Benarroch, A. M. Schmeichel, G. E. Smith, R. C. Petersen, J. E. Ahlskog, et al.
Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism
Neurology, July 8, 2003; 61(1): 40 - 45.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
I. Eisensehr, R. Linke, K. Tatsch, H. von Lindeiner, B. Kharraz, F. J. Gildehaus, R. Eberle, T. Pollmacher, A. Schuld, and S. Noachtar
Alteration of the striatal dopaminergic system in human narcolepsy
Neurology, June 10, 2003; 60(11): 1817 - 1819.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
M.L. Fantini, M. Michaud, N. Gosselin, G. Lavigne, and J. Montplaisir
Periodic leg movements in REM sleep behavior disorder and related autonomic and EEG activation
Neurology, December 24, 2002; 59(12): 1889 - 1894.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
I. Eisensehr, T. C. Wetter, R. Linke, S. Noachtar, H. v. Lindeiner, F. J. Gildehaus, C. Trenkwalder, and K. Tatsch
Normal IPT and IBZM SPECT in drug-naive and levodopa-treated idiopathic restless legs syndrome
Neurology, October 9, 2001; 57(7): 1307 - 1309.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
R. L. Albin, R. A. Koeppe, R. D. Chervin, F. B. Consens, K. Wernette, K. A. Frey, and M. S. Aldrich
Decreased striatal dopaminergic innervation in REM sleep behavior disorder
Neurology, November 14, 2000; 55(9): 1410 - 1412.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.